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An Evidence-Based Review of 
Efficacy and Safety of Dietary, 
Natural Supplements and Sunlight 
in Vitamin D Deficiency
Jenson Mak
Abstract
There have been recent concerns about the propensity of calcium and vitamin D 
supplementation to cause cancer. In osteoporotic patients, this has led to increasing 
recommendations advocating the replacement of calcium supplementation with 
dietary or other means. Around the world, the problem of vitamin D deficiency 
remains, being a large contributor of rickets and osteomalacia in the developing 
world and osteoporosis in post-menopausal women and people dependent on long-
term corticosteroid treatment. We review the alternatives of vitamin D supplemen-
tation through dietary, other natural supplements as well as sunlight therapy, in an 
evidence-based manner. We will also review the safety aspect of each modality.
Keywords: vitamin D deficiency, osteoporosis, rickets, bone health, diet,  
natural supplements
1. Introduction
Vitamin D is a fat-soluble vitamin utilised by human beings for normal bone 
development; maintenance by increasing the absorption of calcium, magnesium 
and phosphate; as well as potential pleiotropic effects on the prevention of cancer, 
heart disease, autoimmune disease, type 2 diabetes and depression [1].
A circulating level of 25-hydroxyvitamin D greater than 30 ng/mL (50 nmol/L) 
is considered a healthy level of vitamin D to maintain. About 1 billion people in the 
world have vitamin D deficiency, ranging from children (leading most notably to 
rickets), pregnant and lactating women, certain racial groups, post-menopausal 
women and the elderly (leading to osteoporosis) [2].
Vitamin D deficiency arises from multiple causes including inadequate dietary 
intake and inadequate exposure to sunlight. About 50–90% of vitamin D is 
absorbed through the skin via sunlight, whilst the rest comes from the diet.
Vitamin D clinical trials have increased over the past decade. Despite these trials, 
studies (including meta-analyses) have provided inconsistent conclusions. Some 
meta-analyses make the assumption that vitamin D is a pharmacological agent, 
and not as a nutrient. Bolland [3, 4] and Zhao’s [5] findings suggest that vitamin D 
supplementation does not prevent fractures or falls (and in fact one study suggested 
it may contribute to falls in community-dwelling older women at higher dosages [6], 
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or have clinically meaningful effects on bone mineral density, and suggested ‘little 
justification to use vitamin D supplements to maintain or improve musculoskeletal 
health’). A recent umbrella review did conclude that most RCTs have been carried 
out in populations that are not vitamin D deficient and, because of this, possible 
beneficial effects from vitamin D supplementation cannot be excluded [7].
Further, complementary medicine supplementation receives less stringent 
regulation for approval to the general public. For example, in Australia, vitamin D 
or other supplements which claim that it ‘may’ improve bone health and general 
well-being are approved on the Therapeutic Goods Administration as an ARTG [8] 
compared with vitamin D as a medication.
Given the urgent need for the general population, clinicians and consumers 
will benefit from the latest evidence for vitamin D supplementation (through diet, 
extraneous supplementation and sunlight therapy), including its efficacy and 
potential harm (Figure 1).
2. Epidemiology
Vitamin D deficiency is a major global public health problem in all aged groups, 
particularly in the Middle East. There is striking lack of data in infants, children 
and adolescents worldwide and in most countries of South America and Africa [9]. 
Figure 1. 
In many countries, there is an abundance of sunlight throughout the entire year. Ironically, the sun-protective 
messages for the primary prevention of skin cancers become stronger than those of the moderate benefits of 
sunlight.
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Of concern, even in countries where there is sun exposure all year-round, reports of 
deficiency is common in infants (90% in Turkey, 46% in black Americans, 96% in 
Kuwait and 99% in Indian), in children (58% in Belgium, 72% in Malaysia and 95% 
in Afghanistan), in adolescents (50% of non-whites in Canada, 46% in China and 
45% in the United Arab Emirates) and in adults (52% of women in New Zealand, 
97% in 62% in Korea and 77% in Brazil).
3. Pathophysiology
Vitamin D is crucial in calcium and vitamin D metabolism, as its absence 
around 15% of dietary calcium and 60% of phosphorus is absorbed. 
1,25-Dihydroxyvitamin D interacts with the vitamin D receptor which increases 
Figure 2. 
Vitamin D Metabolism (From Horlick [10]).
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the intestinal calcium absorption to 40% and phosphorus to 80% (Figure 2, [10]). 
Vitamin D is transformed for activation through two hydroxylations in the body. 
Among the metabolic products or modified versions of vitamin include calcitriol 
(1,25-dihydroxyvitamin D3); the active form of vitamin D, with a 15-hour half-life; 
and calcifediol (25-hydroxyvitamin D3) with a 15-day half-life [10]. Vitamin D is 
bounded to specific receptors located throughout the body. Whilst serum 25(OH)
D levels do not indicate the amount of vitamin D stored in body tissues, it is the best 
indicator of vitamin D status.
When the level was 30 ng/mL or less, there was a significant decrease in 
intestinal calcium absorption that was associated with increased parathyroid 
hormone [10]. Further, there is strong support from reports that maternal vitamin 
D deficiency leads to overt bone disease (congenital rickets) from before birth to 
post-natal life [11]. Throughout the world, there has been widespread debate as to 
the serum 25(OH)D concentrations associated with deficiency (e.g. rickets), for 
optimal bone health and optimal overall health, and most cut points have not been 
developed by an agreed mutual scientific process. The US Institute of Medicine 
concluded that individuals are at risk of vitamin D deficiency at serum 25(OH)D 
concentrations <30 nmol/L (<12 ng/mL). However, some individuals are potentially 
at risk for inadequacy even at levels ranging from 30 to 50 nmol/L (12–20 ng/mL). 
The committee agreed with sufficient levels at ≥50 nmol/L (≥20 ng/mL) and that 
50 nmol/L is the serum 25(OH)D level that covers the majority of needs of the 
population (97.5%) [12].
Further, hypovitaminosis D in its mild but especially in severe forms can 
exacerbate symptomatic hypocalcaemia following intravenous bisphosphonate 
(zoledronic acid) [13]. Even though this is rare, associated hypocalcaemia may be 
life-threatening and require immediate resuscitation and evaluation, often requir-
ing hospitalisation to prevent additional morbidity and mortality risk from tetany, 
refractory hypotension, seizures or arrhythmias. Therefore it makes good sense to 
optimise vitamin D levels prior to administration of these agents [14].
Vitamin D toxicity can occur when blood 25(OH)D levels are 88 ng/mL or 
greater [15]. Symptoms may include sleepiness, vomiting, weakness, headache, 
nausea and constipation, and acute toxicity may cause hypercalcaemia and 
hypercalciuria.
4. Evidence-based review
Whilst there have been several treatment guidelines published, they are con-
sensus-based rather than evidence-based [16–19]. This review seeks to address this 
issue and identify any gaps in research for vitamin D replacement, listing the types 
available including dietary, other supplementation and sunlight, for bone health 
(rickets, osteoporosis) as well as to address safety and efficacy in an evidence-based 
manner.
Systematic search of MEDLINE, CINAHL and EMBASE for articles published 
rom September 2015 to August 2019 and the Cochrane Database of Systematic 
Reviews (most recent issue searched—Issue 2, 2019) was conducted by the author. 
Randomised controlled trials, meta-analyses and reviews of all aspects of vitamin D 
supplementation in humans were reviewed. Articles pertaining to osteoporosis in a 
specific condition (e.g. epilepsy) were excluded.
All studies were reviewed independently by the author, who recorded individual 
study results, and an assessment of study quality and treatment conclusions was 
made according to evidence-based protocols.
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Out of a total of 211 articles from PUBMED for vitamin D supplementation and 
osteoporosis, we found 22 articles satisfying the research criteria. Out of a total of 
54 articles from PUBMED for vitamin D supplementation and rickets, we found 22 
articles satisfying the research criteria. Of the 76 reviews from Cochrane Database 
of Systematic Reviews, there were 4 suitable review articles [20–23].
5. Vitamin D replacement in diet
Human beings require and source vitamin D from diet, dietary supplements and 
exposure to sunlight.
Whilst in particular for older people and those with restriction in diet, a diet rich 
in oily fish (which can theoretically improve 25-OHD levels and prevent vitamin D 
deficiency), in reality this is a challenge to achieve [24]. Only a few foods are a good 
source of vitamin D. These include fortified dairy products and breakfast cereals, 
fatty fish, beef liver and egg yolks.
Apart from the flesh of fatty fish (such as salmon, tuna and mackerel) and fish 
liver oils, very little foods contain vitamin D. Trace amounts of vitamin D can be 
found in egg yolks, cheese and beef liver. These foods contain vitamin D3 and its 
metabolite 25(OH)D3 [25]. Vitamin D2 is contained in some mushrooms [26, 27].
In the standard Western diet, fortified foods provide most of the vitamin D 
[26]. For example, US milk is fortified with 100 IU/cup. (In Canada, by law its milk 
is fortified with 35–40 IU/100 mL and its margarine at ≥530 IU/100 g.) However, 
other dairy products derived from milk, such as ice-cream and cheese, are gener-
ally not fortified. Some ready-to-eat cereals for breakfast often contain small 
amounts of added vitamin D, as do some brands of orange juice and yogurt. Some 
plant-based alternatives to mild (such as drinks made from oats, almond or soy) 
are sometimes fortified with vitamin D to the amount (about 100 IU/cup) found in 
fortified cow’s milk. Several countries of the developed world (e.g. United States, 
Canada and Australia) mandate the fortification of infant formula with vitamin 
D, 40–100 IU/100 kcal in the United States and 40–80 IU/100 kcal in Canada; 
however, this is not practical especially in those who breastfeed and those countries 
which do not mandate fortification of their milk formulas.
6. Sunlight for vitamin D replacement
Most people meet at least some of their vitamin D needs through exposure to 
sunlight [28]. Solar ultraviolet B radiation crosses the skin and converts 7-dehydro-
cholesterol to previtamin D3, which is rapidly converted to vitamin D3. Excessive 
sunlight exposure does not cause intoxication because any excess previtamin D3 or 
vitamin D3 is destroyed by sunlight, and in the skin there is reversible conversion to 
inactive sterols [24].
In residential aged care, practical attempts for therapeutic sunlight therapy have 
produced only mild 25(OH)D3 improvements and depended on the season of expo-
sure [29]. On a practical level, excessive exposure to ultraviolet is the primary cause of 
skin cancer, including squamous cell carcinoma, basal cell carcinoma and cutaneous 
malignant melanoma [30], so this is not a pragmatic approach from a public health 
perspective. Essentially, people with limited sun exposure require good dietary 
sources of vitamin D or take a supplement to achieve recommended intake levels.
Besides increasing sun exposure, the best way to get additional vitamin D is 
through supplementation.
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7. Natural supplements for vitamin D
In fortified foods and supplements, vitamin D is also available in two forms, 
vitamins D2 (ergocalciferol) and D3 (cholecalciferol), that differ in their side-chain 
structure only. Vitamin D2 is manufactured by the UV irradiation of ergosterol in 
yeast, and vitamin D3 is manufactured by the irradiation of 7-dehydrocholesterol 
from lanolin and the chemical conversion of cholesterol [10]. Both forms effectively 
raise serum 25(OH)D levels [28, 31]. It appears that at nutritional doses vitamins D2 
and D3 are equivalent, but at high doses vitamin D2 is less potent.
The recent increase in vitamin D interest by the general public has fuelled a big 
rise in sales of over-the-counter vitamin D preparations. Additionally, products 
with progressively increasing content of over-the-counter vitamin D preparations 
are becoming increasingly prevalent. Many types of pharmaceutical preparations 
for vitamin D supplementation are commercially available, including oily drops, 
capsules and tablets [31].
Individuals at high risk for deficiency should have a vitamin D blood test first; 
a dosage of up to 3000–4000 IU may be required to restore blood concentrations. 
In the Middle East and African countries, vitamin D doses ≥2000 IU/day may be 
needed to reach the target 25(OH)D level ≥20 ng/ml [32].
Whilst for pregnant women and children (1000 IU daily is safe) [33], there are 
very few concerns regarding vitamin D complications; in the elderly and especially 
those who are vitamin D replete, there has been some concerns about increased fall-
ing risks (especially at high doses) [34]. A 1-year, double-blind, randomised clinical 
trial conducted in Switzerland of 200 community-dwelling men and women 70 
years and older with a prior fall, randomised to receiving monthly 24,000 IU 
(low-dose), 60,000 IU of vitamin D3 and 24,000 IU of vitamin D3 plus 300 μg 
of calcifediol, found that the higher-dose groups  increased vitamin D levels more 
effectively but did not improve lower extremity function (over 12 months) and 
indeed increased fall incidence slightly [35]. Whilst this is not a cause for alarm, the 
study does confirm the popular scientific idiom ‘Too much of a good thing is bad 
thing’. Bischoff-Ferrari [36] advocates against regular high-dose bolus or monthly 
moderate doses of vitamin D for fracture prevention. Indeed Zhao [5] in a meta-
analysis of 33 randomised trials involving 51,145 participants found no benefit 
of supplements containing calcium, vitamin D or both compared with places in 
fracture prevention among community-dwelling older adults (over 50 years); 
however, it is noted that the research is limited by the lack of reporting of whether 
participants had osteoporosis, osteopenia or low bone mass, as well as participants 
mainly from Europe and the United States.
In contrast, research on vitamin D replenishment in the mild to moderate 
vitamin D-deficient elderly population following a hip fracture showed that a 
single loading dose of cholecalciferol (250,000 IU vitamin D3, the REVITAHIP 
(Replenishment of Vitamin D in Hip Fracture) strategy) or placebo, both receiving 
daily vitamin D (800 IU) and calcium (500 mg), was able to improve vitamin D 
levels and reduce falls (Figure 3) and pain levels [14]. The REVITAHIP investigators 
adopted a similar loading dose vitamin D followed by maintenance vitamin D at 
800 IU (and calcium) daily supplied to the participants, due to the very high rates 
of vitamin D deficiency noted in the HORIZON Recurrent Fracture study (observed 
in the first 385 patients [37]). The investigators found that virtually all participants 
in the active treatment group reached target vitamin D (>50 nmol/L) at weeks 2 and 
4 compared with the placebo group (Figure 4).
Interestingly, Smith [38], in a group of elderly women (mean age 66 years) 
with hypovitaminosis D (<50 nmol/L), demonstrated that vitamin D followed 
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a U-shaped curve on falls whether analysed by serum dose or serum 25(OH)D3 
levels. The investigators found no decrease in the incidence of falls on low vitamin 
D doses (400, 800 IU), a significant decrease in falls on medium doses (1600, 2400, 
3200 IU) (p = 0.020). Counterintuitively, Smith found no decrease on high doses 
(4000, 4800 IU) compared to placebo (p = 0.55). The rate of falls was 60% in the 
lowest quintile <25 ng/ml (<50 nmol/L), 21% in the low middle quintile 32–38 ng/
ml (80–95 nmol/L), 72% in the high middle quintile 38–46 ng/ml (95–115 nmol/L) 
and 45% in the highest quintile 46–66 ng/ml (115–165 nmol/L). A similar U-shaped 
pattern in the subgroup with a previous fall history was noted among the quintiles 
of 25(OH)D3 levels (Figure 5, [38]).
Conglomerating the results from Bischoff-Ferrari, Lyles, Smith and Mak, there 
does not appear to be any justification in having regular high-dose vitamin D supple-
ments at monthly intervals, due to the risk of vitamin D toxicity, hypercalcaemia 
and perhaps oversaturation of vitamin D receptors on skeletal muscles, leading to a 
propensity to falls. The author would recommend the REVITAHIP strategy of initial 
single loading dose bolus (250,000 IU) followed by regular 800 IU daily [14, 37], or 
24,000 IU monthly [35], supplementation but would recommend to be cautious with 
the Smith approach of medium daily dosages, probably up to 1600 IU daily without 
a bolus [38], for high-risk populations, and would support that larger monthly doses 
of 100,000 IU need further evaluation with respect to efficacy and safety.
Figure 3. 
REVITAHIP Active Vitamin D Protocol (initial 250,000 IU followed by 800 IU Vitamin D3 and 500 mg 
Calcium Daily at 4 weeks shows significance in reducing falls.
Figure 4. 
REVITAHIP Active Vitamin D Protocol (initial 250,000 IU followed by 800 IU Vitamin D3 and 500 mg Calcium 
Daily at 2, 4 and 26 weeks showed significant 25-OHD levels improvements compared with the placebo group.
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8. Conclusions
Vitamin D is an essential fat-soluble hormone with multiple positive pleiotropic 
effects on the human bodies besides the optimisation on bone health. The evidence 
for ensuring high-risk groups such as pregnant women, children and those from the 
Middle East and African countries is vitamin D replete with either dietary, sunlight 
or combination with appropriate vitamin D supplements at moderate doses. For 
community-dwelling older adults with a history of falls, osteoporosis and/or frac-
tures, there is still evidence for a good safety profile for moderate dosages (either 
through an initial single-dose bolus followed by daily low-dose or regular moderate 
daily or monthly dosages). The author does not recommend regular high-dose bolus 
(>500,000 IU bolus) or greater than 50,000 IU monthly given its possible increased 
risk of falls and associated fractures.
Author Note
The author dedicates this chapter to his eldest son Johann, for his constant 
bravery, courage, diligence and dedication to his sport, studies and in life, and to his 
mother Demi, for her constant reminder to strive for perfection.
Figure 5. 
The rate of falls was 60% in the lowest quintile <25 ng/ml (<50 nmol/L), 21% in the low-middle quintile 32-38 
ng/ml (80-95 nmo/L), 72% in the high middle quintile 38-46 ng/ml (95-115 nmo/L) and 45% in the highest 
quintile 46-66 ng/ml (115-165 nmol/L). A similar U-shaped pattern in the subgroup with a previous falls 
history was noted amongst the quintiles of 25(OH)D3 levels [38].
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